Dynavax (DVAX) Tops Q2 EPS by 12c ; Offers Guidance

Dynavax (NASDAQ: DVAX) reported Q2 EPS of $0.03, $0.12 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $56 million versus the consensus estimate of $48.39 million.

GUIDANCE:

Dynavax sees Q3 2023 revenue of $200-215 million, versus the consensus of $193.2 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
• Wall Street scrambles to lift Micron price targets ahead of earnings